Align 4-(gamma-glutamylamino)butanal dehydrogenase (EC 1.2.1.99) (characterized)
to candidate WP_004687625.1 BMI_RS15595 5-carboxymethyl-2-hydroxymuconate semialdehyde dehydrogenase
Query= BRENDA::P23883 (495 letters) >NCBI__GCF_000022745.1:WP_004687625.1 Length = 504 Score = 353 bits (905), Expect = e-101 Identities = 196/470 (41%), Positives = 280/470 (59%), Gaps = 9/470 (1%) Query: 24 INGEYTAAAENETFETVDPVTQAPLAKIARGKSVDIDRAMSAARGVFERGDWSLSSPAKR 83 I GE AAA+ TFET+ PV PLA +A GK+ DIDRA AA+ F +W+ S R Sbjct: 26 IGGEDVAAADGATFETISPVDLKPLATVALGKAADIDRAARAAKAAFP--EWAAMSGDAR 83 Query: 84 KAVLNKLADLMEAHAEELALLETLDTGKPIRHSLRDDIPGAARAIRWYAEAIDKVYGEVA 143 K +L+K+AD + A AEE+A +E +DTG+ ++ + + GA R++A+ + Sbjct: 84 KKLLHKIADAIVARAEEIAFVECMDTGQSLKFMAKAALRGAEN-FRFFADRAPEARDGKT 142 Query: 144 TTSSHELAMIVREPVGVIAAIVPWNFPLLLTCWKLGPALAAGNSVILKPSEKSPLSAIRL 203 ++ M R P+G + I PWN P +L+ WK+ PALAAG +V+ KP+E SPL+A L Sbjct: 143 LRGPGQVNMTTRVPIGPVGVITPWNTPFMLSTWKIAPALAAGCTVVHKPAEFSPLTARLL 202 Query: 204 AGLAKEAGLPDGVLNVVTGFGHEAGQALSRHNDIDAIAFTGSTRTGKQLLKDAGDSNMKR 263 +A+EAGLP GV N+V GFG +AG+AL+ H DI AI F G +RTG ++K D+ +KR Sbjct: 203 VEIAEEAGLPKGVWNLVNGFGEDAGKALTEHPDIKAIGFVGESRTGSLIMKQGADT-LKR 261 Query: 264 VWLEAGGKSANIVFADCPDLQQAASATAAGIFYNQGQVCIAGTRLLLEESIADEFLALLK 323 V E GGK+ +VFAD DL++A A I+ G+ C + +RLL+E SI ++F AL+ Sbjct: 262 VHFELGGKNPVVVFADA-DLERAVDAAVFMIYSLNGERCTSSSRLLVEASIYEKFTALVA 320 Query: 324 QQAQNWQPGHPLDPATTMGTLIDCAHADSVHSFIREGESKGQLLLDG----RNAGLAAAI 379 ++A+ + GHPLDP T +G LI H V +I G S+G + G G + Sbjct: 321 EKAKRIKVGHPLDPETVVGPLIHPVHEKKVLEYIEIGRSEGATVAAGGAKFAGPGGGCYV 380 Query: 380 GPTIFVDVDPNASLSREEIFGPVLVVTRFTSEEQALQLANDSQYGLGAAVWTRDLSRAHR 439 PT+F +++EEIFGPVL F E +AL LAND +YGL +WT D++RA R Sbjct: 381 SPTLFTAAHNGMRIAQEEIFGPVLTAIPFKDEAEALALANDVKYGLTGYLWTNDVTRAFR 440 Query: 440 MSRRLKAGSVFVNNYNDGDMTVPFGGYKQSGNGRDKSLHALEKFTELKTI 489 + L+AG ++VN+ N + PFGG K SG GRD + + + E K I Sbjct: 441 FTDALEAGMIWVNSENVRHLPTPFGGVKNSGIGRDGGDWSFDFYMETKNI 490 Lambda K H 0.317 0.133 0.389 Gapped Lambda K H 0.267 0.0410 0.140 Matrix: BLOSUM62 Gap Penalties: Existence: 11, Extension: 1 Number of Sequences: 1 Number of Hits to DB: 590 Number of extensions: 30 Number of successful extensions: 6 Number of sequences better than 1.0e-02: 1 Number of HSP's gapped: 1 Number of HSP's successfully gapped: 1 Length of query: 495 Length of database: 504 Length adjustment: 34 Effective length of query: 461 Effective length of database: 470 Effective search space: 216670 Effective search space used: 216670 Neighboring words threshold: 11 Window for multiple hits: 40 X1: 16 ( 7.3 bits) X2: 38 (14.6 bits) X3: 64 (24.7 bits) S1: 41 (21.7 bits) S2: 52 (24.6 bits)
This GapMind analysis is from Sep 24 2021. The underlying query database was built on Sep 17 2021.
Each pathway is defined by a set of rules based on individual steps or genes. Candidates for each step are identified by using ublast (a fast alternative to protein BLAST) against a database of manually-curated proteins (most of which are experimentally characterized) or by using HMMer with enzyme models (usually from TIGRFam). Ublast hits may be split across two different proteins.
A candidate for a step is "high confidence" if either:
Otherwise, a candidate is "medium confidence" if either:
Other blast hits with at least 50% coverage are "low confidence."
Steps with no high- or medium-confidence candidates may be considered "gaps." For the typical bacterium that can make all 20 amino acids, there are 1-2 gaps in amino acid biosynthesis pathways. For diverse bacteria and archaea that can utilize a carbon source, there is a complete high-confidence catabolic pathway (including a transporter) just 38% of the time, and there is a complete medium-confidence pathway 63% of the time. Gaps may be due to:
GapMind relies on the predicted proteins in the genome and does not search the six-frame translation. In most cases, you can search the six-frame translation by clicking on links to Curated BLAST for each step definition (in the per-step page).
For more information, see:
If you notice any errors or omissions in the step descriptions, or any questionable results, please let us know
by Morgan Price, Arkin group, Lawrence Berkeley National Laboratory